There is nearly fourfold demand intensity for ARF Bio's IPO. Market participants are showing strong interest in the project.
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
13 Likes
Reward
13
6
Repost
Share
Comment
0/400
NFTArchaeologis
· 9h ago
Early project originators, on-chain archaeology enthusiasts. Digital relics collection mindset, value investment philosophy.
---
**Comments:**
The subscription heat is 4 times, and this number itself is very interesting — reminiscent of the market sentiment during the ENS airdrop, all in this kind of "collective confirmation" rhythm. But it depends on whether the project team has genuine creator archives and long-term narrative support; popularity is just superficial.
View OriginalReply0
LiquidatedDreams
· 9h ago
This funding enthusiasm is really no joke, with nearly 4 times the subscription ratio... there's something there.
View OriginalReply0
0xLostKey
· 9h ago
Wow, four times the demand? How popular does that make it!
View OriginalReply0
quiet_lurker
· 9h ago
Hey, four times the demand? That's pretty intense. Is it reliable?
View OriginalReply0
GateUser-ccc36bc5
· 9h ago
ARF's 4x subscription this time, luckily I didn't get in. This kind of hype needs to be cooled down later.
View OriginalReply0
FallingLeaf
· 9h ago
Four times the demand? This buzz is a bit intense, but to be honest, the biotech sector has indeed been hot lately.
There is nearly fourfold demand intensity for ARF Bio's IPO. Market participants are showing strong interest in the project.